COMP <GO>
ACHV vs NTLA // 10Y YIELD & FRED MACRO BETA
Achieve Life Sciences Inc. (NASDAQ) VS. Intellia Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: ACHV 1
— NTLA 3
■ METRIC PARITY
LAST: $7.19 (+4.96%) • MKT CAP: $739.9M
macro-sensitivity
—
LAST: $13.23 (-0.68%) • MKT CAP: $1.85B
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACHV VS. NTLA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACHV | NTLA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.69% | -21.35% | +14.66 | ACHV | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 16.90% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 1.17 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 4/9 | -2.00 | NTLA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.4 | 53.4 | -7.03 | NTLA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $739.9M | $1.85B | -$1.11B | NTLA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACHV REV | NTLA REV | ACHV GROSS % | NTLA GROSS % | ACHV FCF | NTLA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $67.7M | — | — | -$49.5M | -$395.9M |
| FY 2024 | $0 | $57.9M | — | — | -$29.8M | -$354.7M |
| FY 2023 | $0 | $36.3M | — | — | -$24.5M | -$394.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACHV // BETA —
NTLA // BETA —